Assessing impaired glucose tolerance and insulin resistance in polycystic ovarian syndrome with a muffin test: An alternative to the glucose tolerance test

Endocrine Practice

Volumn 16, Issue 5, 2010, Pages 810-817

  Freeman, Ruth ^a   Pollack, Rena ^b   Rosenbloom, Ella ^c  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b JACOBI MEDICAL CENTER   (United States)

^c MONTEFIORE MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; INSULIN;

ADULT; ARTICLE; BODY COMPOSITION; BODY FAT; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HUMAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MEAL; ORAL GLUCOSE TOLERANCE TEST; OVARY POLYCYSTIC DISEASE; PROSPECTIVE STUDY; RISK FACTOR;

EID: 78149292154     PISSN: 1530891X     EISSN: None     Source Type: Journal    
DOI: 10.4158/EP09330.OR     Document Type: Article

References (20)

1. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352:1223-1236.
2. Mlinar B, Marc J, Janez A, Pfeifer M. Molecular mechanisms of insulin resistance and associated diseases. Clin Chim Acta. 2007;375:20-35.
3. Rotterdam ESHRE/ASRM-Sposored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004;19:41-47.
4. Legro RS, Kunselman AR, Dodson WC, Dunaif A. Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: A prospective, controlled study in 254 affected women. J Clin Endocrinol Metab. 1999;84:165-169.
5. Hsueh WA, Quiñones MJ. Role of endothelial dysfunction in insulin resistance. Am J Cardiol. 2003;92:10J-17J.
6. Haffner SM, Mykkänen L, Festa A, Burke JP, Stern MP. Insulin-resistant prediabetic subjects have more atherogenic risk factors than insulin-sensitive prediabetic subjects: Implications for preventing coronary heart disease during the prediabetic state. Circulation. 2000;101:975-980.
7. Dunaif A, Finegood DT. Beta-cell dysfunction independent of obesity and glucose intolerance in the polycystic ovary syndrome. J Clin Endocrinol Metab. 1996;81:942-947.
8. Kashyap S, Belfort R, Gastaldelli A, et al. A sustained increase in plasma free fatty acids impairs insulin secretion in nondiabetic subjects genetically predisposed to develop type 2 diabetes. Diabetes. 2003;52:2461-2474.
9. Cerf ME. High fat diet modulation of glucose sensing in the beta-cell. Med Sci Monit. 2007;13: RA12-RA17.
10. Harano Y, Miyawaki T, Nabiki J, et al. Development of cookie test for the simultaneous determination of glucose intolerance, hyperinsulinemia, insulin resistance and postprandial dyslipidemia. Endocr J. 2006;53:173-180.
11. Wolever TM, Chiasson JL, Csima A, et al. Variation of postprandial plasma glucose, palatability, and symptoms associated with a standardized mixed test meal versus 75 g oral glucose. Diabetes Care. 1998;21:336-340.
12. McDonald's USA Nutrition Facts for Popular Menu Items. Available at: http://www.mcdonalds.com/app-controller. nutrition. index1.html. Accessed March 3, 2008.
13. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for noninsulin-dependent diabetes mellitus. N Engl J Med. 1986;315:220-225.
14. McAuley KA, Williams SM, Mann JI, et al. Diagnosing insulin resistance in the general population. Diabetes Care. 2001;24:460-464.
15. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31(Suppl 1): S55-S60.
16. Stern SE, Williams K, Ferrannini E, DeFronzo RA, Bogardus C, Stern MP. Identification of individuals with insulin resistance using routine clinical measurements. Diabetes. 2005;54:333-339.
17. Balkau B, Sapinho D, Petrella A, et al; D. E. S. I. R. Study Group. Prescreening tools for diabetes and obesity-associated dyslipidaemia: Comparing BMI, waist and waist hip ratio. The D. E. S. I. R. Study. Eur J Clin Nutr. 2006;60:295-304.
18. Harano Y, Sakamoto A, Izumi K, Shimizu Y, Hoshi M. Usefulness of maltose for testing glucose tolerance. Am J Clin Nutr. 1977;30:924-931.
19. Stefan N, Stumvoll M, Bogardus C, Tataranni PA. Elevated plasma nonesterified fatty acids are associated with deterioration of acute insulin response in IGT but not NGT. Am J Physiol Endocrinol Metab. 2003;284: E1156-E1161.
20. Knowler WC, Barrett-Connor E, Fowler SE, et al; Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346:393-403.